Abstract
P-198: Real-life experience of the combination of daratumumab, bortezomib, melphalan, and prednisone (DVMP) in patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have